Beijing Da Xue Xue Bao Yi Xue Ban
Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing 100044, China.
Published: October 2009
Objective: To investigate the outcome of liver transplantation(LT) for end stage liver disease with portal vein thrombosis (PVT) in different processes.
Methods: Data from 308 patients who underwent LT from July 2004 to February 2008 were retrospectively assessed. The processes of varies grades of PVT during LT were analyzed and estimated for whether the outcome of LT was different between patients with or without PVT.
Results: There were 46 patients with PVT, including 11 of grade 1, 14 of grade 2, 18 of grade 3 and 3 of grade 4. LT performed in grade 1 and 2 PVT patients without special intervention. LT was performed in 16 patients with grade 3 PVT after simple thrombectomy or thrombus-extraction. The other 2 patients with grade 3 PVT received the donor superior mesenteric vein to act as a bridge between the donor portal vein and host superior mesenteric vein. Two cases with grade 4 PVT received a cavo-portal hemitransposition, and the other one anastomosis between graft portal vein and varicose coronary vein. The postoperative 1-year survival rates of patients without PVT and patients with PVT were 91.6%(240/262), 80.5%(211/262)vs 86.9%(40/46), 76.1%(35/46), respectively. The patients with PVT had a recurrence rate of 4.3%(2/46).
Conclusion: Most patients suffering from end stage liver disease with PVT can be successfully treated by LT. However, the result of the patients with diffused PVT undergoing LT is relatively poor.
Download full-text PDF |
Source |
---|
Am J Med
March 2025
Department of General Medicine, Itabashi Chuo Medical Center, Tokyo, Japan.
Trop Anim Health Prod
March 2025
Faculdade de Veterinária, Universidade Federal Fluminense, Av. Vital Brasil Filho, 64, Niterói, RJ, CEP 24230-340, Brazil.
This study aimed to describe the ultrasonographic appearance of the liver, spleen, and kidneys in 35 healthy Santa Inês breed sheep. The spleen was located caudal to the last rib and extended to the 8th intercostal space (ICS), while the splenic vein was predominantly visible between the 11th and 10th ICS, located between the 12th and 9th ICS. The liver was visualized from the 12th to the 7th ICS, with the portal vein exhibiting a mean diameter of 15.
View Article and Find Full Text PDFANZ J Surg
March 2025
Department of Vascular and Transplant Surgery, Monash Medical Centre, Melbourne, Victoria, Australia.
Background: The first pancreas transplant in Australia was performed at Prince Henry's Hospital in 1984 (which subsequently relocated to Monash Medical Centre in 1992) in the setting of a successful pancreas transplant reported from the University of Minnesota in 1966. This study is aimed at reviewing the evolution of surgical technique in pancreas transplants and the surgical outcomes.
Methods: All pancreas transplants were reviewed from 1992 to 2022.
Am J Cancer Res
February 2025
Division of Hepatogastroenterology, Kaohsiung Chang Gung Memorial Hospital Kaohsiung, Taiwan.
Atezolizumab plus bevacizumab (Ate/Bev) and lenvatinib (Len) are first-line therapies for unresectable hepatocellular carcinoma (uHCC). However, Ate/Bev's high cost limits its common use in real-life practice, while Len is usually covered by national health insurance (NHI). We conducted this study to compare their effectiveness and safety in real-world settings.
View Article and Find Full Text PDFAm J Cancer Res
February 2025
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, China.
Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide, with portal vein tumor thrombosis (PVTT) worsening its prognosis and complicating management. The combination of transarterial chemoembolization (TACE) and the targeted agent sorafenib has been proposed to improve treatment outcomes. This study investigates the prognostic factors influencing the effectiveness of this combined treatment in HCC patients with PVTT.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.